Table 3.
Recent Hormone Prescriptions Among Transwomen, by Thromboembolism and Hypertension
| TE (n=19), % (n) | No TE (n=2490), % (n) | HTN (n=49), % (n) | No HTN (n=2290), % (n) | |
|---|---|---|---|---|
| Estrogen | 84 (16) | 78.2 (1948) | 73.5 (36) | 78.7 (1801) |
| Estrogen-Oral | 32 (6) | 37.8 (940) | 24.5 (12) | 38.1 (872) |
| Estrogen-Patch | 5.3 (1) | 2.9 (73) | 4.1 (2) | 2.6 (59) |
| Estrogen-Gel | 0 (0) | 0.2 (5) | 0 (0) | 0.2 (4) |
| Estrogen-Injectable | 52.6 (10) | 38.6 (961) | 44.9 (22) | 39.1 (896) |
| Estrogen-Implant | 0 (0) | 0.2 (4) | 0 (0) | 0.2 (4) |
| Estrogen-Vaginal | 0 (0) | 0.1 (2) | 0 (0) | 0.1 (2) |
| AA/Finasteride | 57.9 (11) | 61.0 (1519) | 51.0 (25) | 61.5 (1408) |
| Progestin | 26.3 (5) | 14.0 (349) | 8.2 (4) | 14.5 (331) |
| Progestin-Oral | 26.3 (5) | 13.9 (345) | 8.2 (4) | 14.3 (327) |
| Progestin-Injection | 0 (0) | 0.2 (5) | 0 (0) | 0.2 (5) |
| Testosterone | 0 (0) | 0.7 (18) | 2.0 (1) | 0.8 (18) |
| Testosterone-Injection | — | — | 2.0 (1) | 0.4 (9) |
| Testosterone-Patch | — | — | — | — |
| Testosterone-Gel | — | — | 0 (0) | 0.4 (9) |